Tovorafenib + Cyp3a Inhibitors (Moderate And Strong) Interaction
Moderateinteraction on record
Description
CYP2C8 inhibitors are predicted to increase tovorafenib exposure, which may increase the risk of adverse reactions. Avoid coadministration.
Mechanism
Tovorafenib is a CYP2C8 substrate; inhibitors increase its exposure
Source: NLP:tovorafenib